ArticleCureus2025
Venovenous Extracorporeal Membrane Oxygenation (ECMO) as a Life-Saving Intervention in Refractory Status Asthmaticus: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute severe asthma, or status asthmaticus, is a life-threatening condition unresponsive to conventional therapies such as inhaled β-agonists, corticosteroids, and non-invasive ventilation. We report a case of a 41-year-old male with refractory bronchospasm and profound respiratory acidosis despite aggressive medical management. Initial extracorporeal CO₂ removal (ECCO₂R) via a continuous renal replacement therapy (CRRT) system was unsuccessful due to blood flow limitations. The patient was transitioned to venovenous extracorporeal membrane oxygenation (VV ECMO), which led to rapid improvement in gas exchange and stabilization of dynamic hyperinflation. Over the next several days, bronchospasm resolved, ventilator settings were optimized, and the patient was successfully weaned off ECMO and extubated. This case highlights the critical role of extracorporeal therapies, particularly VV ECMO, in managing severe asthma exacerbations refractory to conventional treatment, allowing lung rest and improving outcomes. Emerging evidence supports the efficacy of these modalities, warranting further research to standardize their use in status asthmaticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.